First Time Loading...

Biotest AG
XETRA:BIO

Watchlist Manager
Biotest AG Logo
Biotest AG
XETRA:BIO
Watchlist
Price: 41.6 EUR
Updated: May 3, 2024

Wall Street
Price Targets

BIO Price Targets Summary
Biotest AG

Wall Street analysts forecast BIO stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIO is 33.8 EUR .

Lowest
Price Target
Not Available
Average
Price Target
33.8 EUR
19% Downside
Highest
Price Target
Not Available
Biotest AG Competitors:
Price Targets
ARWR
Arrowhead Pharmaceuticals Inc
134% Upside
214450
PharmaResearch Co Ltd
24% Upside
ALKS
Alkermes Plc
52% Upside
OVID
Ovid Therapeutics Inc
157% Upside
FYB
Formycon AG
137% Upside
ELYM
Eliem Therapeutics Inc
46% Downside
EXEL
Exelixis Inc
23% Upside
RCUS
Arcus Biosciences Inc
153% Upside

Revenue
Forecast

Revenue Estimate
Biotest AG

For the last 8 years the compound annual growth rate for Biotest AG's revenue is 3%. The projected CAGR for the next 2 years is 2%.

3%
Past Growth
2%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Biotest AG

For the last 8 years the compound annual growth rate for Biotest AG's operating income is 16%. The projected CAGR for the next 2 years is -5%.

16%
Past Growth
-5%
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Net Income
Forecast

Net Income Estimate
Biotest AG

The compound annual growth rate of Biotest AG's net income for the next 2 years is -51%.

N/A
Past Growth
-51%
Estimated Growth
Estimates Accuracy
97%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIO's stock price target?
Price Target
33.8 EUR

According to Wall Street analysts, the average 1-year price target for BIO is 33.8 EUR .

What is Biotest AG's Revenue forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Biotest AG's revenue is 3%. The projected CAGR for the next 2 years is 2%.

What is Biotest AG's Operating Income forecast?
Projected CAGR
-5%

For the last 8 years the compound annual growth rate for Biotest AG's operating income is 16%. The projected CAGR for the next 2 years is -5%.

What is Biotest AG's Net Income forecast?
Projected CAGR
-51%

The compound annual growth rate of Biotest AG's net income for the next 2 years is -51%.